CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $115.16B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 2.9: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.20%Above 5Y avg (3.06%)
Annual Rate
USD 2.88Paid quarterly
Payout Ratio
76.1%Moderate
Consecutive Growth
16 yrStrong track record
Paying Dividends
26 yr
Payback Period
31.9 yr
Next Ex-Dividend
Sep 25, 2026
Next Payment
Oct 16, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
115.16BUSDvs all stocks (USD)
Trailing P/E
24.67xRevenue (TTM)
36.36BUSDvs all stocks (USD)
Profit Margin
13.20%Beta
0.5660xvs all stocks
52-Week Change
-2.16%vs all stocks
Forward Annual Dividend Yield
3.20%vs all stocks
Market Capitalization
115.16BUSDvs all stocks (USD)
Enterprise Value
138.33BUSDvs all stocks (USD)
Trailing P/E
24.67xForward P/E
14.37xPEG Ratio
1.35xPrice to Sales (TTM)
3.24xPrice to Book (MRQ)
2.38xEnterprise to Revenue
3.80xEnterprise to EBITDA
13.69xGross Margin
65.35%Profit Margin
13.20%Operating Margin
22.05%Return on Assets (TTM)
4.92%Return on Equity (TTM)
9.84%Revenue (TTM)
36.36BUSDvs all stocks (USD)
Revenue per Share (TTM)
28.37USDUpdated Aug 28, 2026Quarterly Revenue Growth
9.90%Gross Profit (TTM)
23.75BUSDvs all stocks (USD)
EBITDA (TTM)
10.17BUSDvs all stocks (USD)
Net Income (TTM)
4.80BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
17.80%Operating Cash Flow (TTM)
7.33BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
4.63BUSDvs all stocks (USD)
Forward Annual Dividend Rate
2.88USDUpdated Aug 28, 2026Forward Annual Dividend Yield
3.20%vs all stocks
Trailing Annual Dividend Rate
2.85USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
3.17%vs all stocks
5-Year Average Dividend Yield
3.06%vs all stocks
Payout Ratio
76.14%Minority Interest (Equity)
609.00MUSDFY2026 · Apr 30, 2026Revenue
36.36BUSDFY2026 · Apr 30, 2026Cost of Goods Sold
12.72BUSDFY2026 · Apr 30, 2026Gross Profit
23.64BUSDFY2026 · Apr 30, 2026Operating Income
6.83BUSDvs all stocks (USD)
Pre-tax Income
6.14BUSDFY2026 · Apr 30, 2026Income Tax Expense
1.30BUSDFY2026 · Apr 30, 2026Net Income
4.84BUSDFY2026 · Apr 30, 2026EBIT
6.85BUSDFY2026 · Apr 30, 2026EBITDA (Income Statement)
10.17BUSDFY2026 · Apr 30, 2026Research & Development
2.87BUSDFY2026 · Apr 30, 2026Selling, General & Administrative
11.78BUSDFY2026 · Apr 30, 2026Other Operating Expenses
386.00MUSDFY2026 · Apr 30, 2026Non-operating Interest Expense
715.00MUSDFY2026 · Apr 30, 2026Net Income from Continuing Operations
4.84BUSDFY2026 · Apr 30, 2026Minority Interests (P&L)
-37.00MUSDFY2026 · Apr 30, 2026Operating Cash Flow
7.15BUSDFY2026 · Apr 30, 2026Free Cash Flow
5.24BUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents (End of Period)
1.95BUSDFY2026 · Apr 30, 2026Income Tax Paid
1.94BUSDFY2026 · Apr 30, 2026Interest Paid
774.00MUSDFY2026 · Apr 30, 2026Starting Profit (CF Statement)
4.84BUSDFY2026 · Apr 30, 2026Depreciation & Amortization
2.96BUSDFY2026 · Apr 30, 2026Deferred Taxes (CF)
51.00MUSDFY2026 · Apr 30, 2026Stock-based Compensation
457.00MUSDFY2026 · Apr 30, 2026Other Non-cash Items
314.00MUSDFY2026 · Apr 30, 2026Change in Accounts Receivable (CF)
-200.00MUSDFY2026 · Apr 30, 2026Change in Other Assets/Liabilities
-1.27BUSDFY2026 · Apr 30, 2026Capital Expenditures
-1.90BUSDFY2026 · Apr 30, 2026Net Acquisitions
-406.00MUSDFY2026 · Apr 30, 2026Purchase of Investments
-8.72BUSDFY2026 · Apr 30, 2026Sale of Investments
8.11BUSDFY2026 · Apr 30, 2026Other Investing Activity
-4.00MUSDFY2026 · Apr 30, 2026Net Investing Cash Flow
-2.93BUSDFY2026 · Apr 30, 2026Long-term Debt Issuance
1.75BUSDFY2026 · Apr 30, 2026Long-term Debt Payments
-2.93BUSDFY2026 · Apr 30, 2026Net Short-term Debt Issuance
9.00MUSDFY2026 · Apr 30, 2026Common Stock Repurchase
-1.03BUSDFY2026 · Apr 30, 2026Common Dividends Paid
-3.64BUSDFY2026 · Apr 30, 2026Other Financing Charges
43.00MUSDFY2026 · Apr 30, 2026Net Financing Cash Flow
-4.75BUSDFY2026 · Apr 30, 2026Shares Outstanding
1.28BSharesUpdated Aug 28, 2026Float Shares
1.28BSharesUpdated Aug 28, 2026Shares Short
14.35MSharesUpdated Aug 28, 2026Short Ratio
1.99daysvs all stocks
Short % of Shares Outstanding
1.12%vs all stocks
% Held by Insiders
0.39%vs all stocks
% Held by Institutions
88.57%vs all stocks
Total Cash (MRQ)
9.22BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
7.20USDUpdated Aug 28, 2026Total Debt (MRQ)
29.15BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5821xCurrent Ratio (MRQ)
2.13xBook Value per Share (MRQ)
38.64USDUpdated Aug 28, 2026Total Assets
93.03BUSDvs all stocks (USD)
Total Current Assets
24.79BUSDFY2026 · Apr 30, 2026Total Liabilities
42.96BUSDFY2026 · Apr 30, 2026Total Non-current Assets
68.24BUSDFY2026 · Apr 30, 2026Total Non-current Liabilities
31.30BUSDFY2026 · Apr 30, 2026Total Current Liabilities
11.66BUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents
1.95BUSDFY2026 · Apr 30, 2026Other Short-term Investments
7.27BUSDFY2026 · Apr 30, 2026Accounts Receivable
6.64BUSDFY2026 · Apr 30, 2026Inventory
5.95BUSDFY2026 · Apr 30, 2026Accounts Payable
2.64BUSDFY2026 · Apr 30, 2026Short-term Debt
1.79BUSDFY2026 · Apr 30, 2026Long-term Debt
26.17BUSDFY2026 · Apr 30, 2026Other Non-current Liabilities
2.06BUSDFY2026 · Apr 30, 2026Common Stock (Book)
0.00USDFY2026 · Apr 30, 2026Retained Earnings
32.64BUSDFY2026 · Apr 30, 2026Total Shareholders' Equity
50.07BUSDvs all stocks (USD)
52-Week Low
73.31USDUpdated Aug 28, 202652-Week High
106.33USDUpdated Aug 28, 202652-Week Change
-2.16%vs all stocks
Beta
0.5660xvs all stocks
50-Day MA
85.06USDUpdated Aug 28, 2026200-Day MA
89.83USDUpdated Aug 28, 2026Avg 10-Day Volume
6.76MSharesUpdated Aug 28, 2026Avg 30-Day Volume
6.95MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
3.73USDUpdated Aug 28, 2026Other Income / Expense
22.00MUSDFY2026 · Apr 30, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.9: safe zoneNotable
Altman Z-Score: 2.90
High earnings qualityNotable
Earnings Quality Score: 1.21
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $115.16B, higher than 95% of all stocks globallySignificant
Market cap (USD): 115,159,878,064Global P95: 26,266,743,019.727
Revenue is $36.36B, higher than 95% of all stocks globallySignificant
Revenue (USD): 36,364,001,280Global P95: 15,102,391,082.578
Levered free cash flow is $4.63B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 4,625,375,232Global P95: 1,235,239,084.501
Companies that share the same coordination system — how they create, deliver, or capture value.
Stryker Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
GSK plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vertex Pharmaceuticals Incorporated
Tier 1ProductionApproval-Gated PipelineRule
Bristol-Myers Squibb Company
Tier 1ProductionApproval-Gated PipelineRuleFlow
Novo Nordisk A/S
Tier 1ProductionApproval-Gated PipelineRule
Regeneron Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Pfizer Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Gilead Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Boston Scientific Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Merck KGaA
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Spectra Systems Corporation
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Salesforce Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Jiangsu Seagull Cooling Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth